AAAAAA

   
Results: 1-9 |
Results: 9
Key targets for the execution of radiation-induced tumor cell apoptosis: The role of p53 and caspases
Authors: Pruschy, M Rocha, S Zaugg, K Tenzer, A Hess, C Fisher, DE Glanzmann, C Bodis, S
Citation: M. Pruschy et al., Key targets for the execution of radiation-induced tumor cell apoptosis: The role of p53 and caspases, INT J RAD O, 49(2), 2001, pp. 561-567
The phosphatidylinositide 3 '-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C
Authors: Tenzer, A Zingg, D Rocha, S Hemmings, B Fabbro, D Glanzmann, C Schubiger, PA Bodis, S Prusch, M
Citation: A. Tenzer et al., The phosphatidylinositide 3 '-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C, CANCER RES, 61(22), 2001, pp. 8203-8210
Differential p53-dependent mechanism of radiosensitization in vitro and invivo by the protein kinase C-specific inhibitor PKC412
Authors: Zaugg, K Rocha, S Resch, H Hegyi, I Oehler, C Glanzmann, C Fabbro, D Bodis, S Pruschy, M
Citation: K. Zaugg et al., Differential p53-dependent mechanism of radiosensitization in vitro and invivo by the protein kinase C-specific inhibitor PKC412, CANCER RES, 61(2), 2001, pp. 732-738
Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance ofthe cytochrome c-mediated caspase-9 death pathway
Authors: Rocha, S Soengas, MS Lowe, SW Glanzmann, C Fabbro, D Winterhalter, K Bodis, S Pruschy, M
Citation: S. Rocha et al., Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance ofthe cytochrome c-mediated caspase-9 death pathway, CELL GROWTH, 11(9), 2000, pp. 491-499
PKC412 - a protein kinase inhibitor with a broad therapeutic potential
Authors: Fabbro, D Ruetz, S Bodis, S Pruschy, M Csermak, K Man, A Campochiaro, P Wood, J O'Reilly, T Meyer, T
Citation: D. Fabbro et al., PKC412 - a protein kinase inhibitor with a broad therapeutic potential, ANTI-CAN DR, 15(1), 2000, pp. 17-28
Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?
Authors: Zaugg, K Bodis, S
Citation: K. Zaugg et S. Bodis, Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?, RADIOTH ONC, 55(2), 2000, pp. 95-99
E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53
Authors: Pruschy, M Wirbelauer, C Glanzmann, C Bodis, S Krek, W
Citation: M. Pruschy et al., E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53, CELL GROWTH, 10(3), 1999, pp. 141-146
Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death
Authors: Hardenbergh, PH Hahnfeldt, P Hlatky, L Takemoto, C Shimamura, A McGill, G Fung, CY Bodis, S Fisher, DE
Citation: Ph. Hardenbergh et al., Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death, INT J RAD O, 43(3), 1999, pp. 601-605
Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
Authors: Pruschy, M Resch, H Shi, YQ Aalame, N Glanzmann, C Bodis, S
Citation: M. Pruschy et al., Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells, BR J CANC, 80(5-6), 1999, pp. 693-698
Risultati: 1-9 |